首页> 美国卫生研究院文献>Molecular Imaging and Radionuclide Therapy >Incidental Detection of a Benign Thymoma on Tc-99m MIBI Myocardial Perfusion Study
【2h】

Incidental Detection of a Benign Thymoma on Tc-99m MIBI Myocardial Perfusion Study

机译:Tc-99m MIBI心肌灌注研究偶然发现良性胸腺瘤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Technetium-99m methoxy-isobutylisonitrile (Tc-99m MIBI) is a routinely used radiopharmaceutical for myocardial perfusion scintigraphy (MPS). It is also a tumor seeking agent. Here, we present a case of 51 year old male who underwent Tc-99m MIBI myocardial perfusion study due to permanent chest pain after coronary angiography. Abnormal MIBI uptake in the thorax was detected in the raw images. This single finding led to further investigation and thoracotomy proved that the lesion was benign thymoma. Thymomas are often asymptomatic or have a non-specific presentation. They are often detected coincidentally on images performed for any other reasons. We wanted to emphasize that during of MPS, the raw data should always be reviewed as occasionally valuable additional information on noncardiac pathology could be recognized by extracardiac uptake, as in this case.>Conflict of interest:None declared.
机译:net 99m甲氧基-异丁基异腈(Tc-99m MIBI)是常规用于心肌灌注显像(MPS)的放射性药物。它也是寻肿瘤剂。在这里,我们介绍了一例51岁的男性,由于冠状动脉造影后永久性胸痛而接受了Tc-99m MIBI心肌灌注研究。在原始图像中检测到胸腔MIBI摄取异常。这一发现导致了进一步的研究,开胸手术证明该病变为良性胸腺瘤。胸腺瘤通常无症状或表现不明确。由于其他原因,通常会在执行的图像上同时检测到它们。我们想强调的是,在MPS期间,应始终检查原始数据,因为在这种情况下,偶尔通过心外膜摄取可以识别出有关非心脏病理学的有价值的其他信息。>利益冲突:未声明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号